Soleno Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the first quarter 2026, Soleno Therapeutics Inc's inventory turnover ratio sequentially decreased to 0.38 in the first quarter 2026, unsurprisingly, as the Soleno Therapeutics Inc markets continue to deteriorate, and SLNO's faces growing challenges to bring down its inventories. Soleno Therapeutics Inc's average inventory processing period in the Mar 31 2026 quarter, has increased to 961 days, from 811 days, in the Dec 31 2025 quarter.

Within Healthcare sector 359 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 0 in the fourth quarter 2025, to 1769.

SLNO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Soleno Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SLNO Inventory Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Inventory Growth	-	-	-	-	-
Y / Y Cost of Sales Growth	-	-	-	-	-
Inventory Turnover Ratio (TTM)	0.38	0.45	0.81	1.18	-
SLNO's Total Ranking	# 1769	# 0	# 0	# 0	# 0
Average inventory processing period	968	813	449	309	-
Seq. Inventory Growth	15.2 %	125.11 %	183.4 %	-	-
Seq. Cost of Sales Growth	38.82 %	-24.36 %	63.94 %	-	-

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 158
Healthcare Sector	# 360
Overall Market	# 1769

Inventory Turnover Ratio Statistics
High	Average	Low
2.3	1.62	0.38
(Sep 30 2016)		(Mar 31 2026)

SLNO Company Profile >> Back to SLNO Efficiency Comparisons >> Compare SLNO Inventory Turnover Ratio to its Competitors

Financial Statements
Soleno Therapeutics Inc's Inventories	$ 17 Millions	Visit SLNO's Balance sheet
Soleno Therapeutics Inc's Cost of Revenues TTM	$ 4 Millions	Visit SLNO's Income Statement
What are SLNO's Sales?		Visit SLNO's Sales by Segment

Other Inventory Turnover Ratios
Soleno Therapeutics Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
SLNO's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for SLNO's Competitors
Inventory Turnover Ratio for SLNO's Suppliers
Inventory Turnover Ratio for SLNO's Customers

You may also want to know
SLNO's Sales Growth Rates	SLNO's Pe Price to earnings ratio	SLNO's Receivables Turnover Ratio	SLNO's Stock Quote
SLNO's Net Income Growth Rates	SLNO's Ps Price to Sales ratio	SLNO's Sales per Employee	SLNO's Asset Turnover Ratio
SLNO's Net Margin	SLNO's Pb Price to Book ratio	SLNO's Financial Strength Ratios	SLNO's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2026	Inventories at quarter ending Mar 31 2026
Envoy Medical Inc	0.61	$ 0.961 Millions	$ 2 Millions
Organogenesis Holdings Inc	0.60	$ 19.764 Millions	$ 33 Millions
Cvrx inc	0.59	$ 7.000 Millions	$ 12 Millions
Gyre Therapeutics Inc	0.59	$ 5.749 Millions	$ 10 Millions
Biomarin Pharmaceutical Inc	0.57	$ 760.883 Millions	$ 1,324 Millions
Envue Medical Inc	0.57	$ 0.708 Millions	$ 1 Millions
Verastem Inc	0.55	$ 0.977 Millions	$ 2 Millions
Heron Therapeutics Inc	0.52	$ 43.000 Millions	$ 82 Millions
Orthopediatrics Corp	0.49	$ 64.000 Millions	$ 130 Millions
Jaguar Health Inc	0.47	$ 4.417 Millions	$ 9 Millions
X4 Pharmaceuticals Inc	0.40	$ 1.639 Millions	$ 4 Millions
Clene Inc	0.40	$ 0.023 Millions	$ 0 Millions
Outlook Therapeutics Inc	0.40	$ 1.408 Millions	$ 4 Millions
Co diagnostics Inc	0.40	$ 0.399 Millions	$ 1 Millions
Regeneron Pharmaceuticals Inc	0.39	$ 1,248.700 Millions	$ 3,191 Millions
Soleno Therapeutics Inc	0.38	$ 3.898 Millions	$ 10 Millions
Guided Therapeutics Inc	0.37	$ 0.196 Millions	$ 1 Millions
Alpha Cognition Inc.	0.31	$ 1.300 Millions	$ 4 Millions
Aditxt Inc	0.31	$ 0.012 Millions	$ 0 Millions
Nexalin Technology Inc	0.31	$ 0.050 Millions	$ 0 Millions
EBR Systems, Inc.	0.30	$ 3.305 Millions	$ 11 Millions
Vystar Corporation	0.27	$ 0.017 Millions	$ 0 Millions
Immunitybio inc	0.25	$ 0.933 Millions	$ 4 Millions
Adagio Medical Holdings inc	0.23	$ 0.431 Millions	$ 2 Millions
Agios Pharmaceuticals Inc	0.20	$ 6.579 Millions	$ 33 Millions
Verrica Pharmaceuticals Inc	0.18	$ 0.400 Millions	$ 2 Millions
Biocorrx Inc	0.17	$ 0.025 Millions	$ 0 Millions
Bioadaptives Inc	0.17	$ 0.007 Millions	$ 0 Millions
Femasys Inc	0.16	$ 0.914 Millions	$ 6 Millions
Apellis Pharmaceuticals Inc	0.15	$ 20.000 Millions	$ 129 Millions

Date modified: 2026-08-30T14:46:59+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.